The pathophysiology of PCD is hypothesized to be from antibodies produced in response to an onconeural antigen; this antigen is the cerebellar degeneration-related protein 2 (CDR2) and is expressed by tumor cells [3]. The gene discussed is CDR2; the disease is paraneoplastic neurologic syndrome.